Unresectable Primary Central Chondrosarcoma
3 clinical trials · Condition
◉ Watch Unresectable Primary Central Chondrosarcoma
| Record | Firm | Date |
|---|---|---|
| Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma (NCT04458922) | National Cancer Institute (NCI) | 2020-10-05 |
| Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma (NCT04340843) | National Cancer Institute (NCI) | 2020-09-08 |
| Vismodegib in Treating Patients With Advanced Chondrosarcomas (NCT01267955) | National Cancer Institute (NCI) | 2010-12-21 |
Track Unresectable Primary Central Chondrosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.